RxDoctor Payments Data

William Golden, MD

Gynecology · Auburn, ALNPI 1598705147

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 16 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by Intuitive Surgical at 31.1% of the total. Reporting peaked in 2019 at $109 and has fallen 80.9% since, to $21 in 2025. That places this record below the midpoint for gynecology clinicians in AL, where the typical reported total is $276.

$276in general payments, 2019–2025

Across 16 payments — averaging $17.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$86
  • Hologic Sales And Service, LLC$83
  • Therapeuticsmd, Inc.$19
  • Astellas Pharma US Inc$17
  • Coloplast$16
  • Minerva Surgical, Inc$14
  • plus $41 from 3 others

What the payments were for

  • Food & beverage$276100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$276 in reported general payments places this provider in the 50th percentile of 51 gynecology providers in Alabama.

See all gynecology providers in Alabama

Medicare billing

Part B allowed, 2024
$9,827
Medicare patients
58
Services billed
112

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron17$9,404
Estradiol-Norethindrone AcetatEstradiol/Norethindrone Acet69$8,750
Estradiol245$7,218
PremarinEstrogens, Conjugated11$6,479
Estradiol (Twice Weekly)Estradiol14$1,958
Clobetasol Propionate19$1,642
ProgesteroneProgesterone, Micronized14$899
Medroxyprogesterone Acetate44$832
Nystatin-TriamcinoloneNystatin/Triamcinolone Acet18$439
ValacyclovirValacyclovir Hcl12$282
Fluconazole16$127

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$17$9,40417 claims
PfizerPremarin$14$6,47911 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 51 gynecology providers in Alabama.

Other gynecology in Auburn

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →